Introduction &
Cancer treatment has made substantial progress in the last few decades, resulting in more survivors [22] . However, cancer and its treatment are still associated with adverse psychosocial and physical side eff ects. Physical side eff ects including fatigue, a decreased muscle strength, reduction of lean body mass, bone mass, and aerobic capacity, causes an overall decrease in the quality of life [7, 8, 37] . Regular physical exercise has been shown to counteract adverse side eff ects of cancer treatment by improving patient ' s health status. Post training eff ects comprise an increase in cardiopulmonary function, muscle strength, bone mineral density, and quality of life, with a reduction in body weight, fat mass and feelings of fatigue [44] . Despite the current physiological insight into cancer-related muscle wasting and the potential benefi cial role of resistance training, which was discussed in the review of Al-Majid et al., most rehabilitation programmes use predominantly ▶ to assess eff ects of resistance training; ▶ to make recommendations for future studies.
Methods

& Database Search
Using database searches of PubMed and Embase, a literature review up to December 2008 was performed, limited to studies in English, German, French and Dutch languages. In addition, bibliographies of previous review articles about exercise and cancer were examined [4, 6, 19, 30, 31, 42, 50] . The search combined key words related to cancer (oncology, neoplasm, tumour, malignancy), cancer treatment (chemotherapy, radiotherapy, surgery, hormonal therapy) and exercise (exercise training, training, physical activity, rehabilitation, resistance training, aerobic training, strength training, lifestyle, endurance, resistance).
Inclusion and exclusion criteria Study design
Included were randomized controlled designs (RCTs), but due to the limited number of studies, non-randomized controlled trials as well as uncontrolled trials published in peer-reviewed journals were also included. Abstracts and case reports were excluded.
Subjects
Included were studies involving adult patients ( > 18 years), diagnosed for malignancy and treated with curative intention. Excluded were studies, in which patients were treated with palliative intention. Studies with children were excluded since in children prevalence of tumour types and treatment are very different as compared to adults.
Intervention
Included were studies prescribing resistance training alone or in combination with other training modalities (e. g. aerobic training).
Timing of the intervention
Only studies prescribing resistance training after chemotherapy were included. Studies prescribing resistance training during chemotherapy were excluded since other exercise targets are involved during treatment, and as a result, probably other intensities, frequencies and durations of exercise are warranted [27] .
Outcome. measures
All outcome measures that were studied in the above selected studies were addressed. The observed eff ects in the intervention studies were graded according to the best-evidence synthesis of Steultjens et al. [55] . The quality of evidence was categorized into strong evidence, moderate evidence, limited evidence, indicative fi ndings or no evidence [2, 55] .
Methodological quality
Study quality was assessed primarily based on the PEDro scale [38] However, two of the three criteria for blinding procedures could not be rated, because in physical activity interventions it is almost impossible to blind patients and care providers to the treatment assignment. Therefore, we applied ten quality criteria (see below), which were rated as follows: yes ( + ), no ( − ), partially ( + / − ), or unclear (? 
Results
& Database search
After selection of a total number of 135 papers, 34 papers were considered potentially relevant. Application of all desired inclusion criteria resulted in a fi nal inclusion of 24 studies [1, 5, 10 -12, 21, 24 -26, 28, 32, 34, 36, 40, 41, 43, 45 -47, 49, 51, 52, 54, 56] , consisting of 10 RCTs [25, 26, 36, 40, 41, 43, 45 -47, 54 ] , 4 controlled clinical trials (CTs) [3, 12, 23, 28] , and 10 uncontrolled trials (Ts) [5, 11, 12, 18, 21, 32, 34, 51, 52, 56] . Three RCTs randomized between two diff erent exercise protocols [25, 40, 43] , and four studies [21, 24, 47, 54] resulted in several publications, but were considered as one study. Table 1 shows the study population of the 24 included studies. Thirteen studies (54 % ) involved a total number of 586 breast cancer patients [5, 25, 26, 28, 32, 34, 36, 41, 45 -47, 52, 56] . Most breast cancer patients received chemotherapy. As shown in
Subjects and timing of intervention • ▶
• ▶ Table 1 , the timing of intervention in breast cancer patients varied considerably, ranging from 2 weeks to 60 months posttreatment. Three studies (13 % ) involved prostate cancer patients, resulting in a total number of 196 patients [11, 21, 54] . All patients received androgen deprivation therapy (ADT), and the timing of interventions ranged from 29 to 47 months after diagnosis. Six studies (25 % ) involved a heterogeneous group of cancer patients [3, 12, 13, 18, 23, 40] , with a timing of intervention that ranged from unspecifi ed to 14 months post treatment. One study selected cancer patients after peripheral blood stem cell transplantation [23] . Latter patients started with a relatively fast intervention (on average 17 days after stem cell infusion). Table 2 shows an overview of the resistance training programmes. The duration of the programmes ranged from 3 to 24 weeks, with a median score of 12 weeks. Most training programmes prescribed 2 or 3 sessions per week. In 20 studies (83 % ) a combination of resistance and aerobic training was applied. Four studies only focused on resistance training [21, 43, 47, 54] . Regarding the prescription of resistance training, only 9 studies (37 % ) were accurate in describing the number of sets and repetitions, or the intensity of the training [5, 12, 13, 21, 23, 26, 36, 43, 54] . In particular, the training intensity was rarely stated, or given in global terms, such as " as tolerated " or " moderate " . Ten studies reported exercise intensities in percentages of one-repetition maximum (1-RM). For upper and lower body exercises and for the abdominal and lower back muscles training intensities varied mostly between 60 -85 % and 30 -60 % of 1-RM, respectively.
Intervention
• ▶
As shown in • ▶ Table 2 , outdoor or treadmill walking and stationary cycling were the most frequently prescribed aerobic exercises. In several training programmes patients could choose their aerobic activity. Intensities of aerobic exercises varied from 40 % to 90 % of maximal heart rate or maximal exercise capacity. Nine studies used a percentage of maximal heart rate to control the training intensity [5, 18, 23, 26, 36, 46, 51, 52, 56] , while fi ve studies prescribed the training intensity by using a percentage of maximal workload or aerobic capacity [12, 13, 28, 32, 34] . [49] , using Dual-Energy X-ray Absorptiometry (DEXA), found a signifi cant increase in lean body mass of 0.88 kg, and a decrease in percentage body fat of 1.15 % after a 6-months training programme. Herrero et al. [26] found a signifi cant increase of 1 kg in muscle mass after an 8-weeks training programme. Muscle mass was indirectly estimated from anthropometrical data by the prediction equation of Lee et al. [35] .
Physical outcome measures • ▶
Cardiopulmonary function
Variables of cardiopulmonary function were assessed in 13 studies, and all studies reported benefi cial eff ects in at least one variable. Peak oxygen uptake, the gold standard for measuring cardiopulmonary function, was assessed in 7 studies [5, 12, 13, 23, 26, 28, 40] . All studies reported signifi cant post training increases from 6 % to 39 % . The largest increase was observed in a study with patients, who underwent stem cell transplantation. Three studies [32, 45, 56] estimated peak oxygen uptake by submaximal testing, and two studies [32, 45, 56] reported signifi cant increases of 15 % . The anaerobic threshold was determined in three studies [12, 13, 18] , and the oxygen uptake, power output or heart rate at the anaerobic threshold increased signifi cantly after training.
Muscle function
Most studies (71 % ) reported outcome measures evaluated by muscle strength and endurance tests, hand grip tests and fl exibility tests. Muscle strength was generally assessed by means of a 1-RM test. To assess upper body and lower body muscle strength both bench press and leg press were mostly applied. As shown in • ▶ Table 3 , muscle strength improved signifi cantly after training. In six studies muscle endurance was measured using the maximal number of repetitions at 60 -70 % of 1-RM [5, 21, 26, 43, 51, 54] .
• ▶ Table 3 showed that muscle endurance improved, except for the bench press in one study [26] .
Lymphedema
Three studies with breast cancer patients focused on lymphedema, a possible complication after axillary node resection [1, 41, 56] . Lymphedema was assessed by measuring arm circumference, arm volume or bio-electric impedance. None of the studies found an increase in these parameters after training.
Immune system
Four studies were focused on the immune system [20, 24, 28, 46] . None of the studies reported negative training eff ects. Hutnick et al. [28] even found in breast cancer survivors, who underwent an exercise programme, an improvement of the immune function as compared with control patients, who did not follow this programme [28] .
Endocrine system
Three studies assessed endocrine parameters after training [20, 36, 49] . Schmitz et al. [49] and Ligibel et al. [36] used the variables fasting blood glucose, insulin levels in blood, and insulin resistance in their study. Ligibel et al. observed in a RCT with breast cancer survivors a signifi cant decrease in insulin levels and a trend toward improvement in insulin resistance after an exercise intervention [36] . Schmitz et al. found a signifi cant decrease in insulin-like growth factor-II after a 6-months training programme. Galvao et al. [20] examined in prostate cancer patients receiving ADT endocrine parameters in serum, including growth hormone (GH), dehydroepiandrosterone (DHEA), and testosterone. Their study showed that a 20-weeks resistance training programme did not compromise the testosterone suppression, whereas elevations in serum GH and DHEA contributed to improvement in physical function [20] .
Haematological variables
Three studies measured Hb concentrations in blood before and after an exercise programme [18, 20, 26] , and reported no change in Hb values after a 5-weeks, 8-weeks or 20-weeks exercise programme.
Quality of the studies &
Ratings of the diff erent quality criteria varied considerably (see Discussion & This review summarizes the research of previous studies that used resistance training in the post-treatment phase of patients with diff erent types of cancer, by focussing on methodological quality, training methods and physical outcome measures.
Subjects and timing of intervention
Most studies involved patients, diagnosed with stage I to III breast cancer, who received adjuvant chemotherapy. Fatigue was BP = blood pressure; VO 2 = oxygen uptake; W = Watt; HR = heart rate; VE = ventilation; RQ = respiratory quotient; AT = anaerobic threshold; Best-evidence synthesis: SE = strong evidence; ME = moderate evidence; LE = limited evidence; IF = indicative fi ndings; NE = no evidence Downloaded by: Vrije Universiteit. Copyrighted material.
reported as the most prevalent and distressing side eff ect of chemotherapy [14] . Compliance to regular physical exercise has been shown to have the potential to break the cycle of fatigue and exercise avoidance [37] . It is obvious that in daily practice the timing of intervention with an exercise programme varied considerably. Some studies started their training programme weeks to months, and other studies months to years after the last treatment. However, starting early after diagnosis seemed to be most appropriate, since a signifi cant decrease in interest in participating in lifestyle interventions has been noted when time elapsed after diagnosis [17] . Also during treatment, exercise has been shown to be successful in the improvement of physical fi tness and thus the capacity for performing activities of daily life [39] . Even exercise before cancer treatment to prepare the body for a stressful event such as chemotherapy has been broached [15] .
Intervention
In all included studies the duration of resistance training programmes lasted 3 -24 weeks, contributing to a variable training response. In our hospital we observed that most progression in muscle strength could be achieved after the fi rst 12 weeks [12] . In seven studies (29 % ) the training duration was shorter than 12 weeks, therefore, patients in these studies will probably not have attained their maximal performance level [3, 5, 18, 26, 41, 46, 56] . Also, the number of training sessions per week (frequency) may aff ect the response to resistance training. Numerous resistance training studies have demonstrated that at least 2 -3 alternating days per week are necessary for an optimal progression in untrained individuals [33] . In fact, most training programmes prescribed 2 or 3 sessions per week. It is of clinical relevance that in most studies exercises, targeting the large muscle groups, were applied, such as leg press and seated row. Since 71 % of cancer survivors are overweight or obese [16] , suffi cient muscle mass involved in exercises is important to evoke metabolic demands that are necessary for reduction in body fat and improvement in lean body mass. No evidence was found for signifi cant training eff ects on body composition or fat mass. Therefore, other strategies besides exercise training (e. g. dietary intervention) will be needed to manage body weight. This is of clinical relevance since excess body weight in cancer survivors may contribute to a high risk for cardiovascular disease and diabetes mellitus [16] . Most studies described training intensities between 60 % and 85 % of 1-RM, or 15-6 RM, which can be considered as moderate to high-intensity training [33] . Only in two studies patients trained at lower intensities between 25 % and 70 % of 1-RM [40, 43] . It is well known that in healthy adult subjects a resistance training programme is more eff ective when relatively heavy loads (high intensity) are used. Substantial gains in maximal muscle strength and hypertrophy can only be achieved when the maximal number of motor units is recruited, which warrants high training loads [33] . In addition, other tissues such as bone also respond more favourably to such heavy loading, because strength training is benefi cial in preventing further bone loss in patients at risk for osteoporosis [48] . This is clinically of importance especially in postmenopausal breast cancer survivors, who might have a lower than normal bone mineral density. The observed training intensities are remarkable high compared with the advised exercise intensities for cancer patients, which can be considered as low to moderate (50 % of 1-RM with 2 or 3 sets of 3 -5 repetitions building to 10 -12 repetitions) [53] . Since none of the moderate to high-intensity training studies reported adverse eff ects, we conclude that moderate to high training intensities are well-tolerated in cancer survivors.
Physical outcome measures
Almost all included studies reported benefi cial eff ects of resistance training on cardiopulmonary function and muscle function. However, since most studies used a mixed training programme, it is unclear whether these improvements could be attributed to the resistance training alone or to the combined resistance / aerobic exercise intervention. Post training improvements in cardiopulmonary function ranged from 6 % to 39 % , with the lowest improvement in studies with a short training duration. Post training increases in muscle strength ranged from 11 % to 110 % . This enormous range in improvement could be attributed to diff erent causes, such as the contribution of a learning eff ect, the variability in strength exercises, intensities and duration of training programmes, and genetic diff erences. Only the study of Herrero et al. [26] described a familiarization session before the fi rst assessment to eliminate learning eff ects. If learning eff ects could be eliminated, the observed range would be smaller. Also the variability in type and stage of cancer, the diff erent cancer treatments and the diff erent times elapsed since cancer diagnosis will contribute to the observed heterogeneity in training responses. Finally, there was general agreement in the absence of adverse eff ects of training on immunological, endocrinological, and haematological variables, or lymphedema, indicating that high training intensities were well-tolerated in cancer survivors.
Methodological quality
Since 10 out of 24 studies were uncontrolled trials, the median quality score of the studies was low (4 on a scale from 1 -10). This was mainly due to the fact that in studies without a control group, a maximum of 7 out of 10 quality criteria could be fulfi lled. Criteria of randomization, allocation concealment, and baseline similarity could not be applied. Three RCTs fulfi lled all quality criteria [26, 43, 54] , of which one randomized between two exercise interventions [43] . Therefore, the studies of Herrero et al. [26] and Segal et al. [54] could be considered an impetus for future studies.
It is obvious that a number of quality criteria were poorly achieved. It is remarkable that not all RCTs blinded their outcome assessors. This criterion is especially important in cases where maximal exercise tests are performed in order that encouragements at the end of the test may not diff er between exercise and control group. Adherence rates were lacking in almost half of the studies. However, the extent to which an intervention group performs the exercise prescription should be an important topic in starting exercise intervention studies [9, 10] to pursue optimal training outcomes. In three studies there was no supervision of the training [11, 25, 34] . Although regular exercise is generally considered a safe procedure, supervision is essential to prevent injuries and to safeguard patients from excessive risks. Finally, the criterion of specifying the type of resistance training was poorly described in most studies. However, for an optimal progression in performance benefi ts, individualization of the training prescription is essential. Based on the health status and needs of the patients, training goals must be determined, involving choices of which muscles must be trained and how injuries can be prevented. After that, the selection, order, and intensity (number of repetitions and sets) of each exercise, as well as the balance between physical activity and rest must be defi ned [33] . For example, a well-defi ned training programme to improve shoulder function is required in breast cancer patients, who might have specifi c post treatment limitations in the shoulder.
Recommendations and future directions
We conclude that resistance training is not only well-tolerated in cancer patients, but also a tool to counteract adverse eff ects of cancer and its treatment. Based on the fi ndings of this systematic review we recommend the following for future studies: ▶ Since most of the research is focused on breast and prostate cancer survivors, future research should incorporate more patients with other types of cancer to determine whether the observed positive eff ects of physical training could be generalized for all cancer types. ▶ Expand the duration of training programmes to at least 12 weeks, with a training frequency of 2 to 3 times a week. Resistance training should be primarily focused on the large muscle groups, with intensities between 60 -85 % of 1-RM and 2 -3 sets of 8 -12 repetitions. ▶ Use valid and reliable physical outcome measures to improve comparability between eff ects of diff erent training programmes (e. g. VO 2 peak, VO 2 AT, upper body strength (1-RM), lower body strength (1-RM)). ▶ Before starting an intervention, high levels of exercise adherence must be warranted. ▶ Before starting a randomized, controlled trial, adequate allocation concealment and blinding of outcome assessors must be warranted. ▶ When reporting the fi ndings, a detailed prescription of the exercise intervention should be provided (frequency, duration, intensity and type of exercise). ▶ Future studies should pay more attention to additional strategies for improvement in body composition (decrease in fat mass and increase in lean body mass) in cancer survivors.
